Infectious Disease In Vitro Diagnostics Market, By Product Type (Instruments/Analyzers, Reagents & Kits, and Software & Services), By Sample Type, By Test Type, By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4039
|
Published Date
June 2025
|
Pages
377
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Infectious Disease In Vitro Diagnostics Market size was valued at US$ 24,546.98 Million in 2024, expanding at a CAGR of 2.67% from 2025 to 2032.
The Infectious Disease In Vitro Diagnostics (IVD) market centers on laboratory-based tests designed to detect pathogens and infections in human samples, playing a critical role in early diagnosis and effective disease management. Market growth is being driven by the rising prevalence of infectious diseases such as tuberculosis, HIV, and emerging viral outbreaks. According to the World Health Organization (WHO), tuberculosis remains one of the top 10 causes of death worldwide, infecting over 10 million people annually. Technological advancements—particularly in molecular diagnostics, point-of-care testing, and AI-integrated diagnostic tools—are significantly improving detection speed, sensitivity, and accuracy.
Public health initiatives and global screening campaigns, especially in low- and middle-income countries, are expanding access to diagnostic testing. However, barriers such as underdeveloped laboratory infrastructure, the high cost of advanced diagnostics, and regulatory challenges continue to hinder widespread market scalability. Despite these issues, the growing need for decentralized testing, increased government funding for disease surveillance, and innovation in portable diagnostic solutions are creating substantial opportunities for market expansion and improved healthcare outcomes.
Infectious Disease In Vitro Diagnostics Market- Market Dynamics
Rising Global Disease Burden and Technological Advancements to Drive Market Growth
The increasing global burden of infectious diseases, coupled with rapid advancements in diagnostic technologies, is driving strong growth in the in vitro diagnostics (IVD) market. According to the World Health Organization (WHO), over 38 million people were living with HIV in 2023, highlighting the critical importance of early detection for timely treatment and preventing transmission. Technological innovations such as rapid molecular assays and CRISPR-based diagnostics are significantly improving the speed and accuracy of testing, particularly in resource-constrained settings. The U.S. Centers for Disease Control and Prevention (CDC) also stresses early testing for infections like hepatitis and tuberculosis to reduce complications and curb community spread. Furthermore, the COVID-19 pandemic highlighted the urgent need for scalable diagnostic infrastructure, leading to increased global government investment in decentralized and point-of-care testing solutions. Together, these factors are reshaping global healthcare strategies, emphasizing proactive disease surveillance and early intervention through advanced, accessible diagnostic tools.
Infectious Disease In Vitro Diagnostics Market- Segmentation Analysis:
The Global Infectious Disease In Vitro Diagnostics Market is segmented based on Product Type, Sample Type, Test Type, Technology, End User, and Region.
The diagnostic market is categorized into three primary product types: Reagents & Kits, Instruments/Analyzers, and Software & Services. Reagents and kits accounted for the largest market share, primarily due to their essential role in routine diagnostics and widespread deployment during public health emergencies such as the COVID-19 pandemic. Instruments and analyzers maintained steady demand, particularly with the adoption of automated, high-throughput platforms that streamline laboratory workflows and reduce human error. Meanwhile, software and services gained momentum through the integration of digital tools, artificial intelligence, and remote diagnostic platforms, enhancing decision-making and expanding access to care. According to the U.S. Centers for Disease Control and Prevention (CDC), federal laboratory and testing initiatives during the pandemic led to a 50% increase in funding for diagnostic reagents and automation tools between 2020 and 2023, accelerating innovation and deployment across healthcare systems.
Based on sample type, the market is divided into five categories: Blood/Serum, Urine, Saliva, Swabs (Nasal, Throat), and Tissue Biopsy. Blood and serum samples were the dominant choice in 2024 due to their high diagnostic accuracy, rapid processing, and compatibility with a wide range of tests including infectious diseases, oncology, and metabolic disorders. Swabs, particularly nasal and throat, remained vital for respiratory disease testing, especially during seasonal flu and COVID-19 surges. Urine and saliva samples supported the growing demand for non-invasive diagnostics in areas such as hormone monitoring, drug testing, and infectious disease screening. Tissue biopsies, though more invasive, remained essential for histopathological and cancer diagnostics. According to the U.S. Department of Health and Human Services (HHS), over 70% of federally funded diagnostic testing programs in 2024 utilized blood/serum samples, reinforcing their status as a diagnostic standard due to reliability and clinical breadth.
Infectious Disease In Vitro Diagnostics Market- Geographical Insights
The Infectious Disease In Vitro Diagnostics (IVD) market demonstrates strong growth potential across both developed and developing regions, driven by varying disease burdens and healthcare infrastructure capabilities. North America continues to lead the market, supported by widespread adoption of advanced diagnostic technologies, well-established regulatory systems, and significant public and private investment in healthcare R&D. Europe follows closely, with strong public health initiatives and cross-border disease surveillance programs funded through EU mechanisms such as the EU4Health Programme, which has allocated over €5 billion (2021–2027) to strengthen health systems and diagnostics.
In the Asia-Pacific region, market expansion is accelerating due to high population density, recurring infectious disease outbreaks, and increasing government prioritization of diagnostic innovation. Countries like India and China are investing in national health programs to expand point-of-care testing and improve rural diagnostic access. For example, India\'s National Health Mission supports decentralized testing to enhance early detection and control of communicable diseases. In Latin America and Africa, while diagnostic infrastructure remains uneven, global health partnerships—such as those led by the World Bank, Gavi, and the Global Fund—are improving access to testing through targeted funding and mobile laboratory initiatives. These regional trends, coupled with sustained global government support, are collectively shaping a dynamic and increasingly equitable IVD landscape for infectious disease management.
Infectious Disease In Vitro Diagnostics Market- Competitive Landscape:
The competitive landscape of the Infectious Disease In Vitro Diagnostics (IVD) market is characterized by a diverse mix of global diagnostic leaders, emerging biotech companies, and manufacturers focused on public health solutions. Established players are heavily investing in research and development to deliver faster, more accurate, and user-friendly diagnostic platforms, particularly in molecular diagnostics and point-of-care (POC) testing. These innovations are often developed in collaboration with hospitals, public health agencies, and international organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), especially during public health emergencies like COVID-19 and Ebola.
The market has seen accelerated innovation through open-access research platforms and emergency use authorizations, especially in PCR and antigen testing. Startups are gaining momentum by introducing AI-powered diagnostic tools and smartphone-integrated testing solutions, which are particularly valuable in low-resource settings. Technological advancements in biosensors, lab-on-a-chip systems, and diagnostic automation are also shaping the future of infectious disease testing. To strengthen their global presence, companies are adopting strategic approaches such as mergers and acquisitions, regional production facilities, and partnerships aimed at localization and faster market access. As demand for decentralized and rapid diagnostics continues to rise, the market is becoming increasingly dynamic and innovation-driven.
Recent Developments:
- August 2024: MP Biomedicals launched a new line of rapid diagnostic kits targeting infectious gastrointestinal diseases, including Helicobacter pylori, Salmonella typhi, and Vibrio cholerae. These CE-marked immunochromatographic tests deliver quick and accurate results, enhancing early diagnosis and patient care.
- October 2024: OCEAN Dx initiated a clinical trial for its rapid sepsis diagnostic test, designed to identify pathogens within hours, enabling early, targeted antibiotic treatment and improving survival rates in sepsis patients.
- April 2025: bioMérieux introduced WATCHFIRE™, a molecular PCR-based testing solution capable of detecting 22 viruses and bacteria in wastewater. Integrated with its FIREWORKS™ software, the platform provides real-time surveillance capabilities to support public health monitoring and outbreak response.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Becton Dickinson (BD)
- BioMérieux SA
- Bio-Rad Laboratories
- Danaher Corporation (Cepheid, Beckman Coulter)
- GenMark Diagnostics
- Hologic, Inc.
- Luminex Corporation
- Meridian Bioscience
- Ortho Clinical Diagnostics
- PerkinElmer, Inc.
- Qiagen N.V.
- Roche Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
- Trivitron Healthcare
- Others
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Instruments/Analyzers
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Virus
- Candida
- TB and drug-resistant TB
- Gastrointestinal panel testing
- Chlamydia
- Gonorrhea
- HPV
- HIV
- Hepatitis C
- Hepatitis B
- COVID-19
- Other
- Reagents & Kits
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Virus
- Candida
- TB and drug-resistant TB
- Gastrointestinal panel testing
- Chlamydia
- Gonorrhea
- HPV
- HIV
- Hepatitis C
- Hepatitis B
- COVID-19
- Other
- Software & Services
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Virus
- Candida
- TB and drug-resistant TB
- Gastrointestinal panel testing
- Chlamydia
- Gonorrhea
- HPV
- HIV
- Hepatitis C
- Hepatitis B
- COVID-19
- Other
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032
- Blood/Serum
- Urine
- Saliva
- Swabs (Nasal, Throat)
- Tissue Biopsy
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Screening Tests
- Confirmatory Tests
- Monitoring Tests
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Immunoassays
- Molecular Diagnostics (PCR, NAAT)
- Microbiological Culture Techniques
- Serology Tests
- Rapid Diagnostic Tests (RDT)
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Diagnostic Laboratories
- Point-of-Care Testing Centers
- Research Laboratories
- Blood Banks
GLOBAL INFECTIOUS DISEASE IN VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Infectious Disease In Vitro Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Infectious Disease In Vitro Diagnostics Market Snippet by Product Type
2.1.2. Infectious Disease In Vitro Diagnostics Market Snippet by Sample Type
2.1.3. Infectious Disease In Vitro Diagnostics Market Snippet by Test Type
2.1.4. Infectious Disease In Vitro Diagnostics Market Snippet by Technology
2.1.5. Infectious Disease In Vitro Diagnostics Market Snippet by End User
2.1.6. Infectious Disease In Vitro Diagnostics Market Snippet by Country
2.1.7. Infectious Disease In Vitro Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Infectious Disease In Vitro Diagnostics Key Market Trends
3.1. Infectious Disease In Vitro Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Infectious Disease In Vitro Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Infectious Disease In Vitro Diagnostics Market Opportunities
3.4. Infectious Disease In Vitro Diagnostics Market Future Trends
4. Infectious Disease In Vitro Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Infectious Disease In Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Infectious Disease In Vitro Diagnostics Market Landscape
6.1. Infectious Disease In Vitro Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Infectious Disease In Vitro Diagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Instruments/Analyzers
7.1.3. MRSA
7.1.4. Streptococcus
7.1.5. Clostridium difficile
7.1.6. VRE
7.1.7. CRE
7.1.8. Respiratory Virus
7.1.9. Candida
7.1.10. TB and drug-resistant TB
7.1.10.1. Gastro-intestinal panel testing
7.1.10.2. Chlamydia
7.1.10.3. Gonorrhea
7.1.10.4. HPV
7.1.10.5. HIV
7.1.10.6. Hepatitis C
7.1.10.7. Hepatitis B
7.1.10.8. COVID-19
7.1.10.9. Other
7.1.11. Reagents & Kits
7.1.11.1. MRSA
7.1.11.2. Streptococcus
7.1.11.3. Clostridium difficile
7.1.11.4. VRE
7.1.11.5. CRE
7.1.11.6. Respiratory Virus
7.1.11.7. Candida
7.1.11.8. TB and drug-resistant TB
7.1.11.9. Gastro-intestinal panel testing
7.1.11.10. Chlamydia
7.1.11.11. Gonorrhea
7.1.11.12. HPV
7.1.11.13. HIV
7.1.11.14. Hepatitis C
7.1.11.15. Hepatitis B
7.1.11.16. COVID-19
7.1.11.17. Other
7.1.12. Software & Services
7.1.12.1. MRSA
7.1.12.2. Streptococcus
7.1.12.3. Clostridium difficile
7.1.12.4. VRE
7.1.12.5. CRE
7.1.12.6. Respiratory Virus
7.1.12.7. Candida
7.1.12.8. TB and drug-resistant TB
7.1.12.9. Gastro-intestinal panel testing
7.1.12.10. Chlamydia
7.1.12.11. Gonorrhea
7.1.12.12. HPV
7.1.12.13. HIV
7.1.12.14. Hepatitis C
7.1.12.15. Hepatitis B
7.1.12.16. COVID-19
7.1.12.17. Other
8. Infectious Disease In Vitro Diagnostics Market – By Sample Type
8.1. Overview
8.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
8.1.2. Blood/Serum
8.1.3. Urine
8.1.4. Saliva
8.1.5. Swabs (Nasal, Throat)
8.1.6. Tissue Biopsy
9. Infectious Disease In Vitro Diagnostics Market – By Test Type
9.1. Overview
9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
9.1.2. Screening Tests
9.1.3. Confirmatory Tests
9.1.4. Monitoring Tests
10. Infectious Disease In Vitro Diagnostics Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
10.1.2. Immunoassays
10.1.3. Molecular Diagnostics (PCR, NAAT)
10.1.4. Microbiological Culture Techniques
10.1.5. Serology Tests
10.1.6. Rapid Diagnostic Tests (RDT)
11. Infectious Disease In Vitro Diagnostics Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals & Clinics
11.1.3. Diagnostic Laboratories
11.1.4. Point-of-Care Testing Centers
11.1.5. Research Laboratories
11.1.6. Blood Banks
12. Infectious Disease In Vitro Diagnostics Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Infectious Disease In Vitro Diagnostics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Infectious Disease In Vitro Diagnostics Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. Becton Dickinson (BD)
13.2.3. BioMérieux SA
13.2.4. Bio-Rad Laboratories
13.2.5. Danaher Corporation (Cepheid, Beckman Coulter)
13.2.6. GenMark Diagnostics
13.2.7. Hologic, Inc.
13.2.8. Luminex Corporation
13.2.9. Meridian Bioscience
13.2.10. Ortho Clinical Diagnostics
13.2.11. PerkinElmer, Inc.
13.2.12. Qiagen N.V.
13.2.13. Roche Diagnostics
13.2.14. Siemens Healthineers
13.2.15. Thermo Fisher Scientific
13.2.16. Trivitron Healthcare
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
